Skip to main content

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Novo Nordisk launches Wegovy® pill in the United Arab Emirates today Wegovy® pill is indicated to reduce excess body weight and maintain weight reduction long-term Wegovy® pill, providing a mean weight loss of 17%, is the only weight-loss pill approved to reduce the risk of major adverse cardiovascular events (MACE), including heart attack and stroke, in adults with established cardiovascular disease and obesity or overweightBagsværd, Denmark, 3 June 2026 – Novo Nordisk today announced the launch of Wegovy® pill (semaglutide tablets) in the United Arab Emirates (UAE), the first country outside the United States to make the Wegovy® pill available to people living with obesity. The launch marks an important step in Novo Nordisk’s ambition to expand access to innovative obesity treatments and broaden treatment options for people...

Continue reading

AS Tallink Grupp Statistics for May 2026

In May 2026, AS Tallink Grupp transported 481,810 passengers, representing a 1.9% increase compared to May 2025. The number of cargo units increased by 1.5% to 22,948 units, while the number of passenger vehicles decreased by 0.6% to 65,104 units compared to the same period a year ago. AS Tallink Grupp passenger, cargo unit and passenger vehicle volumes for May 2026 were as follows:  May 2026 May 2025 ChangePassengers 481,810 472,683 1.9%Finland – Sweden 113,178 108,330 4.5%Estonia – Finland 322,361 313,348 2.9%Estonia – Sweden 46,271 51,005 -9.3%       Cargo Units 22,948 22,605 1.5%Finland – Sweden 3,400 2,377 43.0%Estonia – Finland 18,020 16,808 7.2%Estonia – Sweden 1,528 3,420 -55.3%       Passenger Vehicles 65,104 65,482 -0.6%Finland – Sweden 5,600 4,389 27.6%Estonia...

Continue reading

Regulatory release no. 1 – 2026: Publication of Offering Circular and offer price for the Initial Public Offering and admission of the shares of InstallatørGruppen A/S to trading on Nasdaq Copenhagen

3 June 2026 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering circular, or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017, as amended (the “Prospectus Regulation”) and nothing herein shall be construed as an offering of securities. The offer to acquire securities pursuant to the offering of shares in InstallatørGruppen A/S will be made, and any investment decision by an investor should be made, solely on the basis of information that is contained in the offering circular or prospectus, which is made generally available in Denmark in connection with the offering. Copies of the offering...

Continue reading

Azerion announces CFO transition and strengthens executive leadership through nomination of Sebastiaan Moesman as a member of the Management Board

Amsterdam, 03 June 2026 – Azerion Group N.V. (EURONEXT: AZRN) today announces that Julie Duong Ferat is stepping down from her position as Chief Financial Officer and Executive Committee member.  In good cooperation securing the smooth and seamless continuity of the finance operations, our current Chief Strategy Officer Sebastiaan Moesman has taken the role as acting CFO with immediate effect. As a cornerstone of our executive team, Sebastiaan brings years of strategic and operational expertise to this expanded role. As part of the broader strategy of strengthening and growing Azerion’s statutory governance structure, Sebastiaan is nominated to expand his mandate as Co-CEO to the Management Board alongside CEO Umut Akpinar and the new to be recruited CFO. Any formal appointments will be submitted for shareholder approval at an Extraordinary...

Continue reading

Sigenergy (HKEX: 6656.HK) Launches SigenAgent, a Goal-Based AI Energy Agent for Solar, Storage and EV Charging

Designed to shift energy management from manual device control to goal-based optimization, SigenAgent lets users define outcomes while AI recommends and coordinates execution SHANGHAI, June 03, 2026 (GLOBE NEWSWIRE) — Sigenergy (HKEX: 6656.HK) today announced SigenAgent, a goal-based AI energy management system for solar, energy storage and EV charging. It will be available globally through mySigen App 4.0 in June 2026, delivered to released storage and charging products as a software upgrade with no hardware replacement required. SigenAgent is the centerpiece of Sigenergy’s “AI in All” strategy and is built on one principle — the user sets the goal, the AI does the thinking, and the devices execute. Rather than a chatbot or a dashboard, it understands a user’s objective, breaks it into tasks, generates...

Continue reading

SEALSQ Participates as a Lead Investor in Quobly’s €130 Million Series A Financing Via SEALQuantum.com Fund to Advance the European Sovereign Quantum Infrastructure

Geneva, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES), (“SEALSQ” or “Company”), a leader in post-quantum semiconductor technologies and hardware-anchored security solutions, today announced its participation as a lead investor in Quobly’s €130 million Series A financing. The round is led by ST Microelectronics, SEALSQ, Isalt, and the French Public Investment Bank (BPI France). The SEALSQ investment made via the SEALSQ Quantum Fund, supports Quobly’s industrialization of silicon-based quantum processors and the deployment of its first commercial systems. It strengthens the strategic technical partnership initiated in November 2025 and represents a major milestone in the execution of SEALSQ’s Quantum Vertical Sovereign Stack strategy. As part of this investment, Carlos Moreira,...

Continue reading

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare’s Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

BEIJING, June 02, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that updated data from the Company’s novel BCL2 inhibitor mesutoclax in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) has been released at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentation titled “Safety, tolerability, and efficacy of mesutoclax (ICP-248) in combination with azacitidine in patients with myeloid malignancies”, demonstrating outstanding efficacy and safety. As of April 20, 2026, among evaluable treatment-naïve (TN) MDS patients, the overall response rate (ORR) per IWG 2006 criteria was 100%, including a complete response (CR) rate of 40%, and marrow CR...

Continue reading

Astera Labs Expands Taiwan Operations to Accelerate Global AI Infrastructure Buildout

Expanded Cloud-Scale Interop Lab and growing engineering presence to strengthen AI system integration with leading AI platform providers and Taiwan system manufacturers TAIPEI, Taiwan, June 03, 2026 (GLOBE NEWSWIRE) — Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced a significant expansion of its Taiwan operations and Cloud-Scale Interop Lab, deepening the company’s engineering, operational footprint, and strategic coordination with customers and ecosystem partners in one of the world’s most important semiconductor ecosystems. As AI labs race to stand up training and inference capacity for frontier models, time-to-deployment increasingly depends on how quickly silicon, systems, and manufacturing partners can qualify designs, resolve issues,...

Continue reading

CAPREIT Announces Results of 2026 Annual Meeting

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, June 02, 2026 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN) (“CAPREIT”) announced today that, at its Annual Meeting of Unitholders held today (the “Meeting”), each of the items of business referred to in its management information circular dated April 9, 2026 (the “Circular”) were passed by a vote held by ballot. A total of 108,456,903 units and special voting units of CAPREIT (collectively, “Units”), in the aggregate, representing 70.13% of CAPREIT’s issued and outstanding Units were voted in connection with the Meeting. The voting results for each item of business are as follows: Election of Trustees: All nominees proposed in the Circular were elected as trustees.Nominee VotesFor %...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.